Rallybio Corporation
RLYB
$14.35
$0.322.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.01% | 239.68% | 40.24% | 50.40% | 45.44% |
| Total Depreciation and Amortization | -90.00% | 9.38% | -23.53% | -20.00% | -16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.40% | -1,021.91% | -11.98% | 0.98% | -17.09% |
| Change in Net Operating Assets | 153.30% | 73.27% | -111.85% | -334.08% | -115.27% |
| Cash from Operations | 52.56% | 51.64% | 19.57% | 33.98% | 15.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 349.52% | 31.62% | 16.91% | 7.96% | -109.30% |
| Cash from Investing | 349.52% | 31.62% | 16.91% | 7.96% | -109.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -66.67% | -- | -99.82% | -- | -75.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -66.67% | 100.00% | -99.81% | -- | -75.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.45% | 162.19% | -102.81% | 116.87% | -313.96% |